Symbol Technologies, Inc. v. Lemelson Medical

277 F.3d 1361, 2002 WL 89019
CourtCourt of Appeals for the Federal Circuit
DecidedJanuary 24, 2002
DocketNo. 00-1583
StatusPublished
Cited by18 cases

This text of 277 F.3d 1361 (Symbol Technologies, Inc. v. Lemelson Medical) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Symbol Technologies, Inc. v. Lemelson Medical, 277 F.3d 1361, 2002 WL 89019 (Fed. Cir. 2002).

Opinions

MAYER, Chief Judge.

Symbol Technologies, Inc., Accu-sort Systems, Inc., Intermec Technologies Cor[1363]*1363poration, Metrologic Instruments, Inc., PSC Inc., TeMogix Corporation, Zebra Technologies Corporation, (collectively “Symbol”), and Cognex Corporation (“Cog-nex”) appeal the judgment of the United States District Court for the District of Nevada dismissing various counts of their complaints for failure to state a claim. Symbol Tech., Inc., et al., v. Lemelson Med., Educ. & Research Found., Ltd. P’ship, 99 CV 0397 (D.Nev. Mar. 21, 2000). Because the district court incorrectly concluded that the defense of prosecution laches was unavailable as a matter of law, we reverse the judgment and remand the case.

Background

Lemelson Medical, Education & Research Foundation, Limited Partnership (“Lemelson”) claims to be the assignee of some 185 unexpired patents and many pending patent applications of Jerome H. Lemelson. The patents at issue generally involve machine vision and automatic identification technology and allegedly are entitled to the benefit of the filing date of two applications filed in 1954 and 1956.

Symbol and Cognex (collectively “plaintiffs”) design, manufacture, and sell bar code scanners and related products. In 1998, their customers began to receive letters from Lemelson stating that the use of the plaintiffs’ products infringed various Lemelson patents. Plaintiffs claim that they will be forced to indemnify these customers should any of the patents be found to be infringed.

Symbol brought a declaratory judgment action pursuant to 28 U.S.C. § 2201(a) (1994), against Lemelson, the owner of U.S. Patents 4,338,626; 4,969,038; 4,979,-029; 4,984,073; 5,067,012; 5,119,190; 5,119,205; 5,128,753; 5,144,421; and 5,351,078, seeking a judgment that the patents are invalid, unenforceable, and not infringed by Symbol or its customers. Symbol Tech., Inc., et al, v. Lemelson Med., Educ. & Research Found., Ltd. P’ship, 99-CV-0397. Cognex brought a similar action (CV-N-99-0533-PMP) adding U.S. Patents 4,118,730; 4,148,061; 4,511,918; 5,023,714; 5,249,045; and 5,283,641. Cognex Corp. v. Lemelson Med., Educ. & Research Found., Ltd. P’ship, 99-CV-0533. The gravamen of the complaints most pertinent to us is prosecution laches. The trial court consolidated the cases.

Lemelson moved for dismissal arguing that there was no case or controversy and that the plaintiffs’ cause of action for prosecution laches failed to state a claim upon which relief could be granted. The district court concluded that there was a sufficient case or controversy but dismissed plaintiffs’ laches claims. The sole issue on appeal is whether, as a matter of law, the equitable doctrine of laches may be applied to bar enforcement of patent claims that issued after an unreasonable and unexplained delay in prosecution even though the applicant complied with pertinent statutes and rules.

Discussion

In reviewing the propriety of decisions under Fed.R.Civ.P. 12(b)(6), we apply the rule of the regional circuit — in this case the United States Court of Appeals for the Ninth Circuit. Phonometrics v. Hospitality Franchise Sys., Inc., 203 F.3d 790, 793, 53 USPQ2d 1762, 1764 (Fed.Cir.2000). Therefore, consistent with the rule in the Ninth Circuit, we review the decision below de novo, and “[a]ll allegations of material fact are taken as true and construed in the light most favorable to the nonmoving party.” O’Loghlin v. County of Orange, 229 F.3d 871, 874 (9th Cir.2000); accord Advanced Cardiovascular Sys., v. Scimed Life Sys. ., Inc., 988 F.2d 1157, 1160, 26 USPQ2d 1038, 1041 (Fed.Cir. [1364]*13641993). We have jurisdiction pursuant to 28 U.S.C. § 1292(b) & (c).

The defense of prosecution laches finds its origin in two Supreme Court cases: Woodbridge v. United States, 263 U.S. 50, 44 S.Ct. 45, 68 L.Ed. 159 (1923); and Webster Electric Co. v. Splitdorf Electrical Co., 264 U.S. 463, 44 S.Ct. 342, 68 L.Ed. 792 (1924). The Court first applied the doctrine in Woodbridge to render a patent unenforceable where there had been an unexplained nine-year delay. Pursuant to a statute in place at the time, the Patent Office agreed to delay the issuance of Woodbridge’s patent for one year. At the end of that time, the Patent Office neglected to issue the patent. Rather than inform the Patent Office of its error, Woodbridge waited nine years before requesting that the patent be issued. At the time of issuance, he sought to amend his specification and claims to encompass related innovations that had occurred in the intervening nine years. Woodbridge justified these actions on the ground that his invention had only recently become “pecuniarily” valuable. 263 U.S. at 51-53, 44 S.Ct. 45. The Court held that because of his delay, he had forfeited his rights to the patent. “In this case we have a delay of nine years and a half in securing a patent that might have been had at any time in that period for the asking, and this for the admitted purpose of making the term of the monopoly square with the period when the commercial profit from it would have been highest.... Meantime other inventors had been at work in the same field ... without knowledge of the situation with respect to Woodbridge’s invention .... This is not a case of abandonment. It is a case of forfeiting the right to a patent by designed delay.” Id. at 56, 44 S.Ct. 45.

The Court applied the doctrine in Webster a year later and held that an unreasonable eight-year delay rendered the claims at issue unenforceable. In that case, Kane filed a patent application in 1910 that ultimately issued in 1916. In 1915, while the original application was still pending, Kane filed a divisional application copying nine claims of a recently issued patent for the purpose of provoking an interference. After losing the interference, he filed two additional claims, claims 7 and 8, which issued in 1918 and were the subject of the litigation. These claims had not been involved in the earlier interference. “During all of this time the subject-matter [of the claims] was disclosed and in general use; and Kane and his assignee, so far as claims 7 and 8 are concerned, simply stood by and awaited developments.” 264 U.S. at 465, 44 S.Ct. 342. In holding claims 7 and 8 unenforceable, the Court stated, “[w]e have no hesitation in saying that the delay was unreasonable, and, under the circumstances shown by the record, constitutes laches, by which the petitioner lost whatever rights it might otherwise have been entitled to.” Id. at 466, 44 S.Ct. 342. The Court went on to say that a two-year delay was prima facie evidence of unreasonableness. Id. at 471, 44 S.Ct. 342.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hyatt v. Stewart
Federal Circuit, 2025
Hyatt v. Matal
District of Columbia, 2018
Hyatt v. Iancu
332 F. Supp. 3d 113 (D.C. Circuit, 2018)
Cancer Research Technology v. Barr Laboratories, Inc.
679 F. Supp. 2d 560 (D. Delaware, 2010)
Tafas v. Doll
559 F.3d 1345 (Federal Circuit, 2009)
Lucent Technologies, Inc. v. Microsoft Corp.
544 F. Supp. 2d 1080 (S.D. California, 2008)
Digene Corp. v. VENTANA MEDICAL SYSTEMS, INC.
476 F. Supp. 2d 444 (D. Delaware, 2007)
Reiffin v. Microsoft Corp.
270 F. Supp. 2d 1132 (N.D. California, 2003)
In Re Stephen B. Bogese II
303 F.3d 1362 (Federal Circuit, 2002)
Chiron Corp. v. Genentech, Inc.
268 F. Supp. 2d 1139 (E.D. California, 2002)
Symbol Technologies, Inc. v. Lemelson Med
277 F.3d 1361 (Federal Circuit, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
277 F.3d 1361, 2002 WL 89019, Counsel Stack Legal Research, https://law.counselstack.com/opinion/symbol-technologies-inc-v-lemelson-medical-cafc-2002.